摘要
目的 分析血管活性药物治疗心力衰竭患者用微量泵进行药物输入的护理措施。方法 将我院接受治疗的80例使用血管活性药物的心里衰竭患者参与本次试验，参与试验的患者均在2021年11月至2022年11月期间来到我院。根据双盲法将患者进行分类，每组40例，研究组和参照组。参照组采用传统护理方式，研究组在传统护理方式的基础上采用微量泵进行输入药物。分析护理前后心脏功能指标、护理合意度等指标。结果 研究组患者心脏功在护理前后改善对比参照组更为明显（p＜0.05），且研究组的护理更符合患者心意，组间数据对比有差异（p＜0.05）。结论 在用血管活性药物治疗的患者使用微量泵进行输入时，对患者心脏功能的改善效果更为明显。
关键词： 微量泵；血管活性药物；心力衰竭
Abstract
Objective To analyze the nursing measures of drug input by micropump in patients with heart failure treated by vasoactive drugs. Methods 80 patients with heart failure who were treated with vasoactive drugs in our hospital were enrolled in this trial. All the patients who participated in the trial came to our hospital from November 2021 to November 2022. Patients were classified according to double-blind method, with 40 patients in each group, study group and reference group. The reference group adopted the traditional nursing mode, and the study group adopted the micro-pump for drug input on the basis of the traditional nursing mode. The indexes of cardiac function and nursing desirability before and after nursing were analyzed. Results The improvement of cardiac function in the study group before and after nursing was more obvious than that in the reference group (p < 0.05), and the nursing in the study group was more in line with the patients' wishes, and there were differences in data comparison between groups (p < 0.05). Conclusion In the patients treated with vasoactive drugs, the improvement of cardiac function is more obvious when micropump is used.
Key words： Micropump; Vasoactive drugs; Heart failure
参考文献 References
[1] 尚晨黧,高珊,王丽超. 静脉微量泵入大剂量呋塞米治疗心力衰竭(重度)临床疗效观察[J]. 中西医结合心血管病电子杂志,2018,6(17):53,56.
[2] 央忠泽仁. 探析微量泵输注多巴胺及速尿用于治疗肺心病难治性心力衰竭的疗效[J]. 医药前沿,2017,7(25): 26-27.
[3] 陶维柱,刘冰. 左西孟旦联合微量泵持续泵入呋塞米治疗难治性心力衰竭的临床探讨[J]. 中国医药指南,2017, 15 (6): 94-95.
[4] 武学军,闫文静. 硝普钠与多巴胺微量泵入治疗肾功能不全性顽固性心力衰竭的临床观察[J]. 医学综述,2014, 20(16):3026-3027.
[5] 周利娟. 护理干预在微量泵入硝普钠治疗高血压合并心力衰竭患者中的应用价值[J]. 中国药物经济学,2015 (4):146-147.
[6] FRESIELLO, L., ZIELIŃSKI, K., JACOBS, S., et al. Reproduction of continuous flow left ventricular assist device experimental data by means of a hybrid cardiovascular model with baroreflex control[J]. Artificial Organs, 2014, 38(6): 456-468.
[7] 郭俊青. 硝普钠微量泵注射治疗慢性肺源性心脏病合并心衰的临床观察和护理[J]. 中国实用医药,2016,11 (20): 211-212.
[8] 李立青,马嘉琳. 心电监护下微量泵输入多种血管活性药物治疗重症心力衰竭的临床护理观察[J]. 中国医药科学,2022,12(6):105-108.
[9] 胡彩珍,梁健英,梁映霞,等. 心力衰竭患者应用血管活性药物不良反应因素分析与防范对策[J]. 护理实践与研究,2019,16(20):64-65.
[10] 代梅礼. 多元化护理联合新型血管活性药物对慢性心力衰竭患者的效果分析[J]. 临床医药文献电子杂志, 2021,8(22):49-51.
[11] 冯丽钦,牛玉萍,展丽元,等. CCU难治性心力衰竭患者使用微量泵从CVC导管处输注多种血管活性药物的护理[J]. 中国保健营养（中旬刊）,2013(9):250-250,251.